Pitt Shield

A multi-frequency sparse hemispherical ultrasound phased array for microbubble-mediated transcranial therapy and simultaneous cavitation mapping.

Authors: Deng L, O'Reilly MA, Jones RM, An R, Hynynen K

Focused ultrasound (FUS) phased arrays show promise for non-invasive brain therapy. However, the majority of them are limited to a single transmit/receive frequency and therefore lack the versatility to expose and monitor the treatment volume. Multi-frequency arrays could offer variable transmit focal sizes under a fixed aperture, and detect different spectral content on receive for imaging purposes. Here, a three-frequency (306, 612, and 1224 kHz) sparse hemispherical ultrasound phased array (31.8 cm aperture; 128 transducer modules) was constructed and evaluated for microbubble-mediated transcranial therapy and simultaneous cavitation mapping. The array is able to perform effective electronic beam steering over a volume spanning (-40, 40) and (-30, 50) mm in the lateral and axial directions, respectively. The focal size at the geometric center is approximately 0.9 (2.1) mm, 1.7 (3.9) mm, and 3.1 (6.5) mm in lateral (axial) pressure full width at half maximum (FWHM) at 1224, 612, and 306 kHz, respectively. The array was also found capable of dual-frequency excitation and simultaneous multi-foci sonication, which enables the future exploration of more complex exposure strategies. Passive acoustic mapping of dilute microbubble clouds demonstrated that the point spread function of the receive array has a lateral (axial) intensity FWHM between 0.8-3.5 mm (1.7-11.7 mm) over a volume spanning (-25, 25) mm in both the lateral and axial directions, depending on the transmit/receive frequency combination and the imaging location. The device enabled both half and second harmonic imaging through the intact skull, which may be useful for improving the contrast-to-tissue ratio or imaging resolution, respectively. Preliminary in vivo experiments demonstrated the system's ability to induce blood-brain barrier opening and simultaneously spatially map microbubble cavitation activity in a rat model. This work presents a tool to investigate optimal strategies for non-thermal FUS brain therapy and concurrent microbubble cavitation monitoring through the availability of multiple frequencies.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To develop and evaluate a three-frequency sparse hemispherical ultrasound phased array for transcranial microbubble-mediated therapy and simultaneous cavitation mapping.
Animal model / Human subject rat, Sprague-Dawley, not reported, not reported
Disease model healthy
Targeted brain region(s) Brain
Target coordinates not reported

Outcomes and Safety

Summary of Outcomes The multi-frequency FUS array successfully opened the BBB in rats and enabled cavitation mapping.
Duration of biological effect not reported
Safety-related matter No adverse effects reported.

Brain Region

Ultrasound Parameters

Ultrasound instrument Three-frequency (306, 612, 1224 kHz) sparse hemispherical ultrasound phased array (31.8 cm aperture; 128 transducer modules)
FUS Frequency 306 kHz
FUS Intensity not reported
FUS Pressure 0.53 MPa
FUS Mode not reported
Pulse duration 10 ms
Duration of a single FUS session 60 s
Focal Characteristics Focal depth: none; Focal length: none; Aperture size: 31.8 cm

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search